MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Navis Medical tries to guide endovascular procedures
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Navis Medical Corp.
Navis Medical’s variable control guidewire system is designed to replace multiple catheters and guidewires with a single device.
Officers
Richard Ganz
OmniMedics has a heart attack Band-Aid
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
OmniMedics, Melrose, Mass.
OmniMedics is developing a Band-Aid-sized emergency signaling device for sudden cardiac arrest.
Officers
Ron Greene, CEO
Jim Miraldi, COO &CFO
Lightouch Medical measures blood glucose through the skin
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Lightouch Medical, Bryn Athyn, Pa.
Lightouch Medical is developing a device that takes blood glucose measurements through the skin of the finger.
Officers
Donald Schmucker, President & CEO
George Shaheen, VP
Joseph Chaiken, CSO
Paul Shaheen, Co-Founder & Director
Ralph Brill, Consultant
Solace Therapeutics wins tech competition
Solace Therapeutics capped a big week with a win at the MassMEDIC 11th Annual Medtech Investors Conference, landing the first MedTech Ignite 10k Innovative Technology Competition award.
The Framingham, Mass.-based medical device maker won CE Mark approval in the European Union Oct. 1 for its intravesical system to treat female stress urinary incontinence.
Allegro Diagnostics targets lung cancer
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Allegro Diagnostics, Boston
Allegro Diagnostics’ BronchoGen aims to improve the ability to diagnose lung cancer.
Officers
Dan Rippy, President & CEO
Aeris Therapeutics’ lung foam
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Aeris Therapeutics, Woburn, Mass.
Aeris is developing an adhesive foam for lung-volume reduction treatments.
Officers
David Dove, President & CEO
Edward Ingenito, CSO & Medical Director
I-Denti-Fied will tag your teeth
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
I-Denti-Fied Inc., Crown Point, Ind.
I-Denti-Fied’s product suite enables dentists to tag teeth and dental work with patients’ medical information and integrate the data into digital medical records.
Officers
Steven Wise, President & CEO
Kevin Brunski, CMO
James Hickerson Sr., VP of Sales & Marketing
Biorasis and its wireless implantable glucose sensor
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Biorasis, Storrs, Conn.
Biorasis is developing a a wireless, miniaturized, implantable glucose sensor for long-term diabetes management.
Officers
Ioannis Tomazos, CEO
Fotios Papadimitrakopoulos, VP of Research
Faquir Jain, VP of Research
Wadsworth Medical can heal your wounds – needle-free
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Wadsworth Medical, Westborough, Mass.
Wadsworth’s DermaLOC is a needle-free acute wound closure disposable.
Officers
Andrew Fox, Founder & President
Robopsy’s disposable biopsy robot
MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
Robopsy, Boston
Robopsy’s disposable robot aims to help take biopsies during CT scans.
Officers
Nevan Hanumara
Conor Walsh
Alexander Slocum
Rajiv Gupta
MassDevice Network
@MassDevice
LinkedIn
YouTube